SIK1 and neoplasm: Consistent with the findings of previous studies reporting that SIK1 prevents metastasis and tumor invasion [16], we found that SIK1 can be down-regulated in T-LBL tumour tissues, suggesting its association with the T-LBL disease progression and its potential use as predictor marker for patient risk stratification at diagnosis.